CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) [Phase 2]
Summary
A Phase 2 clinical trial update from Stanford University is recruiting to evaluate ketamine’s rapid effects on obsessive-compulsive disorder and explore the inv…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: RECRUITING